Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy-Reference-Cited by-同舟云学术

Functional promoter rs2868371 variant of HSPB1 associates with radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with radio(chemo)therapy

Published:2011-11 Issue:2 Volume:101 Page:271-277
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Lopez Guerra Jose Luis,Wei Qingyi,Yuan Xianglin,Gomez Daniel,Liu Zhensheng,Zhuang Yan,Yin Ming,Li Minghuan,Wang Li-E,Cox James D.,Liao Zhongxing

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference40 articles.

1. Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation;Kelly;Int J Radiat Oncol Biol Phys,1996

2. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy;Wei;Int J Radiat Oncol Biol Phys,2006

3. Once-daily radiotherapy to > or =59.4Gy versus twice-daily radiotherapy to > or =45.0Gy with concurrent chemotherapy for limited-stage small-cell lung cancer: a comparative analysis of toxicities and outcomes;Watkins;Jpn J Radiol,2010

4. A phase I/II radiation dose escalation study with concurrent chemotherapy for patients with inoperable stages I to III non-small-cell lung cancer: phase I results of RTOG 0117;Bradley;Int J Radiat Oncol Biol Phys,2010

5. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes;Fernandes;Radiother Oncol,2010

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of an immune-related lncRNA-miRNA-mRNA regulatory network in radiation-induced esophageal injury in rats;International Immunopharmacology;2023-09

2. Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology;Seminars in Radiation Oncology;2023-07

3. Radiogenomics in lung cancer: Where are we?;Lung Cancer;2023-02

4. Definitive Chemoradiotherapy Results in Synchronous Oligometastatic Non–small Cell Lung Cancer Patients;American Journal of Clinical Oncology;2021-11-30

5. Low dose ionizing radiation effects on the immune system;Environment International;2021-04